Real-Word Evidence Generation System Will Be A Priority For Califf As FDA Commissioner
Executive Summary
At his Senate confirmation hearing, Robert Califf said he wants to establish a system, built on electronic medical records, that can be used to more quickly confirm the benefits and risks of accelerated approval drugs.
You may also be interested in...
Dr. Califf Returns To US FDA: What To Do First?
Acting commissioner Janet Woodcock will remain at the agency and become principal deputy commissioner when Califf arrives.
Dr. Califf Returns To US FDA: What To Do First?
Acting commissioner Janet Woodcock will remain at the agency and become principal deputy commissioner when Califf arrives.
CMS Needs Regulatory Science, Chief Scientist To Coordinate With US FDA, Former Official Says
Sean Tunis embraces a bigger decision-making role for CMS in product access, while FDA Commissioner nominee Robert Califf also calls for smoother FDA-CMS hand-offs, and CBER Director Peter Marks wants a quicker FDA-CDC approval and deployment process.